USP is developing digital reference standards to integrate into modern digital environments, enhancing regulatory confidence ...

This week's report explores the pharmaceutical industry’s evolution toward resilient, scalable systems that prioritize ...

Pharma and advanced therapy manufacturing will only grow more complex in science, regulation, and global scale. But the ...

"Breakthrough new drugs such as specialized oncology treatments as well as new applications for existing drugs — like GLP-1 ...

In a statement sent to PREMIUM TIMES on Friday, CEPI said the project is designed to address long-standing challenges around the cost, supply and deployment of the vaccine, particularly in ...

Patient advocate Howard Chang’s visit to Boehringer Ingelheim’s biopharmaceutical facility revealed both how biologic ...

According to MarketsandMarkets™, the RFID Market is expected to grow from USD 14.58 billion in 2025 to USD 30.47 billion by ...

The PTFE Membrane Market is poised for growth due to rising pharmaceutical demands and stricter water treatment regulations. Opportunities lie in expanding applications in biopharma, wastewater ...

The Global High Content Screening Market presents opportunities in predictive drug discovery driven by increased R&D ...

Centre amends NDCTR-2019 to ease rules for approval of new drugs & investigational new drugs: Gireesh Babu, New Delhi Friday, January 23, 2026, 08:00 Hrs [IST] The Union health mi ...

According to MarketsandMarkets, the RFID Market is expected to grow from USD 14.58 billion in 2025 to USD 30.47 billion by 2034, at a CAGR of ...

Diamyd Medical is taking the next step in a long-term manufacturing collaboration with APL and, in parallel, is initiating a strategic collaboration with NorthX Biologics to further develop and scale ...